Pay in 4 interest-free payments of $6.35 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Antimicrobial bonus: KPV has direct antimicrobial activity against Staphylococcus aureus and Candida albicans at picomolar concentrations (Cutuli et al
New here
Intended Use: For Laboratory Research Use Only Key Characteristics of Tirzepatide (50 mg) Dual incretin receptor-targeted peptide for metabolic research Designed to activate both GIP and GLP-1 receptors in controlled experimental models C20 fatty acid side-chain modification supports enhanced molecular stability and prolonged receptor interaction Amino acid substitutions increase resistance to enzymatic degradation High purity confirmed through HPLC and mass spectrometry Lyophilized form preserves structural integrity before reconstitution Ideal for in vitro studies and preclinical metabolic research models How Tirzepatide (50 mg) Supports Research Tirzepatide (50 mg) is used in laboratory experiments to study the dual activation of GIP and GLP-1 receptors
23,24 CLINICAL STUDIES Many clinical trials have been completed with oral semaglutide in support of the manufacturer's submission to the FDA seeking approval for the treatment of T2DM
US$ 23.71
US$ 23.23
US$ 23.15
US$ 26.07
US$ 24.57
US$ 26.74
US$ 27.20
US$ 22.42
US$ 27.07
US$ 21.80
US$ 27.48
US$ 22.91
US$ 25.39
US$ 23.23
